Traditional Chinese medicines: Regulatory and scientific challenges

被引:0
|
作者
Edgar, M [1 ]
机构
[1] Ancile Pharmaceut Inc, Chem Mfg & Control, San Diego, CA USA
关键词
botanical; herbal medicine; GMP; Traditional Chinese Medicine; pharmaceutical drugs; validation; fingerprinting; and Chemistry; Manufacturing and Control;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Development of multi-component botanical products as pharmaceutical drugs requires control of consistency. The foundation for consistency, which provides the basis for establishing comprehensive specifications is based on control of the biomass and thorough characterization of the extract. Validation of the manufacturing process ensures that the specifications are reproducible. Traditional Chinese Medicines require a special focus on defining the composition of the pharmaceutical product to be developed, understanding the biomass pretreatment chemistry, characterizing the multiple herb mixture, and conforming to drug Good Manufacturing Practices (GMP).
引用
收藏
页码:177 / 190
页数:14
相关论文
共 50 条
  • [41] Safety monitoring of traditional Chinese medicines in China
    Chen, YX
    DRUG SAFETY, 2006, 29 (04) : 352 - 352
  • [42] Dissecting Traditional Chinese Medicines by Omics and Bioinformatics
    Quan, Yuan
    Wang, Zhong-Yi
    Xiong, Min
    Xiao, Zheng-Tao
    Zhang, Hong-Yu
    NATURAL PRODUCT COMMUNICATIONS, 2014, 9 (09) : 1391 - 1396
  • [43] Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications
    Zuanji Liang
    Yunfeng Lai
    Meng Li
    Junnan Shi
    Chi Ieong Lei
    Hao Hu
    Carolina Oi Lam Ung
    Chinese Medicine, 16
  • [44] Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications
    Liang, Zuanji
    Lai, Yunfeng
    Li, Meng
    Shi, Junnan
    Lei, Chi Ieong
    Hu, Hao
    Ung, Carolina Oi Lam
    CHINESE MEDICINE, 2021, 16 (01)
  • [45] Regulatory mechanisms of natural compounds from traditional Chinese herbal medicines on the microglial response in ischemic stroke
    Ri, Myong Hak
    Xing, Yue
    Zuo, Hong Xiang
    Li, Ming Yue
    Jin, Hong Lan
    Ma, Juan
    Jin, Xuejun
    PHYTOMEDICINE, 2023, 116
  • [46] Organic Integration of Traditional Chinese and Western Medicines-Future of Clinical Practice Guidelines of Integrated Traditional Chinese and Western Medicines
    Xie, Ying-lan
    Han, Fei
    Jin, Ying-hui
    Ding, Yan-bing
    Guo, Jing
    Ji, Dong-xiao
    Zhang, Teng
    Chen, Xiao-min
    Shang, Hong-cai
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2024, 30 (04) : 359 - 365
  • [47] Scientific understanding of toxicity and safety of Chinese medicines
    Chang-xiao Liu
    Chinese Herbal Medicines, 2018, 10 (02) : 107
  • [48] Scientific understanding of toxicity and safety of Chinese medicines
    Chang-xiao Liu
    Chinese Herbal Medicines, 2018, (02) : 107 - 107
  • [49] Scientific understanding of toxicity and safety of Chinese medicines
    Liu, Chang-xiao
    CHINESE HERBAL MEDICINES, 2018, 10 (02) : 107 - 107
  • [50] Regulatory control of Chinese proprietary medicines in Singapore
    Yee, SK
    Chu, SS
    Xu, YM
    Choo, PL
    HEALTH POLICY, 2005, 71 (02) : 133 - 149